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Abstract
Background: T-cell responses against dormancy-, resuscitation-, and reactivation-associated antigens of Mycobacterium
tuberculosis are candidate biomarkers of latent infection in humans.
Methodology/Principal Findings: We established an assay based on two rounds of in vitro restimulation and intracellular
cytokine analysis that detects T-cell responses to antigens expressed during latent M. tuberculosis infection. Comparison
between active pulmonary tuberculosis (TB) patients and healthy latently M. tuberculosis-infected donors (LTBI) revealed
significantly higher T-cell responses against 7 of 35 tested M. tuberculosis latency-associated antigens in LTBI. Notably, T cells
specific for Rv3407 were exclusively detected in LTBI but not in TB patients. The T-cell IFNc response against Rv3407 in
individual donors was the most influential factor in discrimination analysis that classified TB patients and LTBI with 83%
accuracy using cross-validation. Rv3407 peptide pool stimulations revealed distinct candidate epitopes in four LTBI.
Conclusions: Our findings further support the hypothesis that the latency-associated antigens can be exploited as
biomarkers for LTBI.
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Introduction
In the vast majority of individuals, specific cellular immunity
against M. tuberculosis is capable of controlling infection leading to
latent M. tuberculosis infection (LTBI) [1]. LTBI is thought to be
associated with a dormancy/non-replicating state of low metabolic
activity of the pathogen. Dormancy-related (DosR) antigens as
well as proteins expressed during reactivation and resuscitation of
dormant bacilli are candidate biomarkers for LTBI and disease
reactivation [2,3,4]. A limited number of studies tested latency-
associated antigens in immunologic assays. These showed that
DosR antigens induced T-cell cytokine expression in humans [5]
and mice [6]. Resuscitation-promoting factors (rpf) induced
immune responses in mice [7] but have not been tested in
humans. Recent studies based on M. tuberculosis knock-out strains
revealed that Rv3407, a protein which is not expressed in M. bovis
BCG at detectable abundance [8], is under the control of two rpf
[9]. Neither Rv3407 nor reactivation-associated antigens (i.e.
Rv0104, Rv1115 [10]) have been tested for immunogenicity so far.
For reasons of comprehensibility we use the term latency-
associated antigens for M. tuberculosis proteins involved in
dormancy, resuscitation, and reactivation of M. tuberculosis.
We tested the immunogenicity of 35 latency-associated antigens
using different assays based on intracellular cytokine staining for
IFNc and IFNc-ELISA. IFNc is a crucial mediator of protection
against tuberculosis which strongly depends on T helper type-1
immunity. IFNc activates infected macrophages at the site of
bacterial residence - an essential mechanism for the killing of
mycobacteria [11]. IFNc release in response to immunodominant
antigens (i.e. ESAT6, CFP10) is used in standard tests for M.
tuberculosis infection (IFNc release assays, IGRA) [12].
IGRA as well as standard intracellular cytokine staining
methods are based on short-term incubation between 6 and
24 h [13]. Principally short-term assays detect recent M. tuberculosis
infection while prolonged in vitro stimulation increases sensitivity
for LTBI [14,15,16]. Yet, these assays remain insufficient as robust
correlates of protection against M. tuberculosis [17]. Therefore,
biomarkers which reliably predict protective immunity are
urgently needed [18]. Antigens predominantly expressed by
dormant M. tuberculosis during LTBI are promising candidate
immune markers of protection [5]. We therefore decided to
develop an assay based on two rounds of in vitro restimulation, to
determine IFNc production in response to M. tuberculosis latency-
associated antigens in LTBI, TB patients, and tuberculin skin test
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tested for their capacity to discriminate between LTBI and TB
patients. Finally, overlapping peptide pools were applied to
identify immunogenic epitopes of the most promising candidate,
Rv3407.
Results
Two-rounds of in vitro restimulation detect T-cell
responses against latency-associated antigens
We assessed 29 antigens associated with M. tuberculosis
dormancy, resuscitation, and reactivation (in short latency,
Table 1) for their potential to elicit recall responses after 16 h
short-term in vitro stimulation of PBMC from LTBI. We detected
IFNc expression in CD4
+CD45RO
+ memory T cells from LTBI
after stimulation with PPD from M. tuberculosis and, to a minor
degree, with M. tuberculosis-immunodominant proteins
ESAT6_CFP-10, TB10.4, and Ag85a (figure 1A). Notably, none
of the latency-associated antigens induced detectable cytokine
expression after 16 h in LTBI (figure 1A) and no T-cell responses
against M. tuberculosis-specific antigens were detected in 10
tuberculin skin test (TST)-negative donors (data not shown).
Increased T cell-derived IFNc responses after prolonged in vitro
incubation have been described [5,14,16]. Since our own previous
experiments indicated that a second stimulation before measure-
ment with the same antigen is optimal for intracellular cytokine
detection (data not shown), we combined 7 days of stimulation
with restimulation 16 h prior to analysis. Frequencies of IFNc-
expressing T cells in PBMC from LTBI were markedly increased
after stimulation with immunodominant proteins or PPD for 7
days (figure 1B, upper graph). In contrast to the short-term single
stimulation assay, latency-associated antigens induced IFNc
expression in memory T cells from the majority of LTBI in the
long-term restimulation assay (figure 1B, upper graph). Two of
these latency-associated antigens, namely Rv0569 and Rv3407,
induced IFNc expression comparable to the ESAT6_CFP-10
fusion protein, the immunodominant antigen which induced the
highest frequencies of cytokine-expressing cells in LTBI. In
contrast, none of the antigens induced detectable IFNc expression
in T cells from TST-negative donors in this assay (figure 1B, lower
graph). Hence, the ‘‘7-day two rounds of restimulation’’ assay
detects specific T-cell responses in LTBI which are missed by the
16h short-term assay.
Comparisons for the individual donor T-cell responses after 7
days and two rounds of restimulation revealed comparable results
against three selected immunodominant antigens (i.e.
ESAT6_CFP-10, TB10.4, Ag85A) and three latency-associated
antigens (i.e. Rv0569, Rv1734, Rv2003) (data not shown).
Considering significantly higher proportions of T cells specific
for immunodominant antigens in the short-term assay, a simply
‘boosted’ T-cell response by prolonged stimulation would not
explain equal proportions since this would have led to higher
proportions of T cells specific for immunodominant antigens in the
7-day assay.
Analyses of IFNc in supernatants by ELISA at day 7 following
two rounds of restimulation revealed a similar tendency for PPD,
immunodominant, and latency-associated M. tuberculosis proteins
in LTBI (figure 2A). In contrast to intracellular staining, a
considerable amount of IFNc was also detected in supernatants of
PBMC from some TST-negative donors after stimulation with
latency-associated antigens (figure 2B). Therefore intracellular
measurement of IFNc after two rounds of in vitro restimulation
revealed higher specificity as compared to the IFNc ELISA.
Significantly stronger T-cell responses in LTBI as
compared to TB patients against latency-associated
antigens
The expression of the vast majority of antigens used in this study
has been associated with latent stages of M. tuberculosis infection.
Consequently, we addressed the question whether these antigens
are differentially recognized by T cells from patients with active
pulmonary TB and LTBI. Eleven latency-associated antigens (i.e.
Rv0569, Rv1733c, Rv1734, Rv2003, Rv2005c, Rv2006, Rv0140,
Rv1009, Rv1884c, Rv2450c, and Rv3407), which induced strong
responses in LTBI, were selected for these experiments. Seven of
these latency-associated antigens induced significantly higher T-
cell responses in LTBI as compared to TB patients (P,0.001 for
Table 1. List of proteins candidates.
Name Category
ESAT6_CFP-10 Immunodominant M. tuberculosis proteins
TB10.4
Rv3019c
Ag85A
Ag85B
Hsp65
Rv0081 DosR* regulon-encoded M. tuberculosis proteins [2]
Rv0569
Rv0573c
Rv1733c
Rv1734
Rv1735c
Rv1736c
Rv1996
Rv1997_C term
Rv1997_N term
Rv1998
Rv2003
Rv2005c
Rv2006
Rv2032
Rv2623
Rv2624c
Rv2625c
Rv2628
Rv3126c
Rv3129
Rv3133c
Rv0140 M. tuberculosis reactivation-associated proteins [10]
Rv1115
Rv0867c M. tuberculosis resuscitation promoting factors [30]
Rv1009
Rv1884c
Rv2450c
Rv3407 M. tuberculosis resuscitation-associated protein [19]
*M. tuberculosis dormancy-related antigens.
doi:10.1371/journal.pone.0005590.t001
T Cells against Latent Mtb
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5590Rv1733c, Rv2003, Rv2005c, Rv0140, and Rv3407; P,0.01 for
Rv1009; P,0.05 for Rv2450c) (figure 3A).
We set a threshold of 0.2% IFNc
+, CD4
+, CD45RO
+ T cells
(i.e. 20-fold above the assumed flow cytometric detection threshold
of 0.01%) to define positive T-cell responses against latency-
associated antigens in LTBI and TB patients for the most
promising candidates (P,0.001) (Table 2). Latency-associated
antigens induced T-cell responses in the range of 45.5 to 72.7% of
LTBI patients. A specific T-cell response against Rv2003 was
detected in the vast majority of LTBI (16 of 22) but also induced
Figure 1. IFNc-expressing CD4
+ CD45RO
+ T cells after 16 h and 7 days restimulation with immunodominant and latency-associated
antigens from LTBI and TST-negative controls. Intracellular cytokine expression after 16 h restimulation in PBMC from LTBI (A), and 7 days –
including two rounds of in vitro restimulation – in PBMC from LTBI (B, upper graph) and TST-negative donors (B, lower graph) are shown. Scatter plots
indicate mean and standard deviation. Percentages of IFNc-expressing CD4
+ CD45RO
+ memory T cells are indicated on the y-axis for SEB, PPD from
M. tuberculosis, and tested antigens (x-axes). Background values of non-stimulated controls were subtracted for each individual donor. The most
promising candidate Rv3407 is underlined. PPD: purified protein derivative of M. tuberculosis; SEB: Staphylococcus enterotoxin B.
doi:10.1371/journal.pone.0005590.g001
T Cells against Latent Mtb
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resuscitation-associated antigen Rv3407 [19] induced positive T-
cell responses in 12 LTBI (55%) but in none of the TB patients.
These results prompted us to determine whether T-cell responses
against M. tuberculosis antigens are sufficient for classification of TB
patients and LTBI.
T-cell responses against latency-associated antigens
discriminate between LTBI and TB patients
We included the 11 immunogenic latency-associated antigens
together with ESAT6_CFP-10, and PPD in a discrimination
approach. Random forest analyses together with leave-1-out
cross-validations across all possible combinations were applied to
determine the prediction accuracy and relative importance of
each factor for classification. These analyses revealed a cross-
validated prediction accuracy of 83% between TB patients and
LTBI (figure 3B). The relative feature importance for discrim-
ination showed that Rv3407 was by far the most influential
factor for classification (figure 3C). Consequently we designed
overlapping peptide pools of Rv3407 to identify immunogenic
epitopes.
Identification of immunogenic peptides of Rv3407
The matrix design of the overlapping peptide pools leads to six
‘vertical’ and five ‘horizontal’ pools. Each of the 29 peptides of
Rv3407 was present in two pools (Table 3). In 6 out of 10 LTBI
tested – those with the highest T-cell response against Rv3407 – a
minimum of 0.2% IFNc-expressing CD4
+ T cells was detected
after stimulation with at least two of the peptide pools (figure 4). In
four LTBI (LTBI-A to LTBI-D) a major immunogenic epitope
could be identified (figure 4A–D) while in two LTBI (LTBI-E,
LTBI-F) with the weakest response against the Rv3407 protein no
prominent epitope-specific T-cell responses were observed
(figure 4E–F). Notably peptide 6 (LRQHASRYLARVEAG)
identified in LTBI-A induced IFNc expression in about 1% of
CD8
+ memory T cells, as well (data not shown). Therefore distinct
peptide epitopes in different LTBI were recognized by antigen-
specific T cells and ongoing studies will determine whether this is
due to differential HLA-phenotypes.
We consider the detection of specific T-cell immunity against
latency-associated antigens and the identification of immunogenic
epitopes an initial step towards definition of reliable biomarkers for
protective immunity against TB.
Figure 2. IFNc ELISA analyses after restimulation with immunodominant and latency-associated antigens of PBMC from LTBI and
TST-negative donors. Analyses of IFNc in the culture supernatant by ELISA after 7 days and two rounds of in vitro restimulation in PBMC from LTBI
(A) and TST-negative donors (B) are shown. Scatter plots indicate mean and standard deviation. Background values of non-stimulated controls were
subtracted. IFNc concentrations in the supernatant are indicated on the y-axis for stimulation with SEB, PPD from M. tuberculosis, and tested antigens
(x-axes). The most promising candidate Rv3407 is underlined.
doi:10.1371/journal.pone.0005590.g002
T Cells against Latent Mtb
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T-cell immunity in LTBI is crucial for protection against
resuscitation and reactivation of M. tuberculosis. We established two
rounds of in vitro restimulation assay that induced specific T-cell
immunity against latency-associated antigens which were not
detected in a short-term T-cell assay. These intracellular IFNc
responses were significantly increased in LTBI as compared to TB
patients. This assay was highly specific since IFNc-expressing
memory T cells were only detected in PBMC from LTBI and not
from TST-negative donors.
We identified a subgroup of latency-associated antigens that
induced significantly stronger T-cell responses in LTBI as
compared to TB patients. This is in accordance with a previous
study that showed increased responses against the latency-
Figure 3. Comparison of IFNc-expressing CD4
+ T cells specific for immunodominant and latency-associated M. tuberculosis
antigens between patients with TB, LTBI, and TST-negative donors. (A). Percentages of IFNc-expressing CD4
+ CD45RO
+ memory T cells are
shown for stimulation with SEB, PPD from M. tuberculosis, and 11 latency-associated antigens after 7 days and two rounds of in vitro restimulation. T-
cell responses from TST-negative donors are indicated as green circles, LTBI are indicated as blue squares, and TB patients are indicated as red
triangles. Two-sided p-values for the Mann-Whitney U-test are indicated as follows: * P,0.05, ** P,0.01; and *** P,0.001. (B) Classification of TB
patients and LTBI based on random forest analysis using 11 latency-associated antigens as well as ESAT6_CFP-10, and PPD. Results from the cross
validation are shown in a bar chart. Each bar represents an individual donor. TB patients are shown on the left (red bars), LTBI on the right side (blue
bars). The y-axis indicates the prediction threshold calculated by random forest analysis. Negative bars predict a TB patient, positive bars an LTBI. The
prediction probability is represented as the bar height. (C) Mean decrease of class impurity over all trees measured as Gini index (y-axis) indicates the
relative importance of each factor (x-axis) for classification. PPD: purified protein derivative of M. tuberculosis; SEB Staphylococcus enterotoxin B.
doi:10.1371/journal.pone.0005590.g003
Table 2. Positive T-cell responses against latency-associated
antigens.
Antigen LTBI
1(%) TB patients
1(%)
Rv2003 16 (72.7) 5 (25)
Rv1733c 15 (68.2) 2 (10)
Rv3407 12 (54.5) 0 (0)
Rv2005c 12 (54.5) 3 (15)
Rv0140 10 (45.5) 2 (10)
1Number of donors with more than 0.2% IFNc-producing T cells.
doi:10.1371/journal.pone.0005590.t002
T Cells against Latent Mtb
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[5]. The remaining candidates (i.e. DosR regulon-encoded
proteins Rv2003 and Rv2005c, the reactivation-associated protein
Rv0140, the resuscitation promoting factors Rv2450c and
Rv1009, as well as Rv3407) have not been tested so far. Rv3407
induced IFNc in T cells exclusively of LTBI. We identified
Rv3407 previously by comparative proteomics of M. tuberculosis
strain H37Rv and M. bovis BCG [8,19]. Rv3407 improved the
vaccine efficacy of BCG suggesting that subunit vaccination can be
used to improve pre-existing protection evoked by BCG [19].
Ongoing studies in our institute aim at characterizing the
biological and antigenic role of Rv3407. Furthermore all
immunogenic protein candidates identified in this study will be
analyzed for the induction of protective T-cell responses in TB
high-incidence countries (www.biomarkers-for-tb.net).
T-cell responses against this subgroup of latency-associated
antigens classified LTBI and TB patients with an accuracy of 83%
and Rv3407 contributed significantly to discrimination. The
discrimination efficacy was comparable to studies of blood cell
counts and ex vivo serum cytokine analyses in fast and slow
treatment responders [20] and was only slightly lower than RNA-
based candidate markers in PBMC from TB patients and LTBI
[21] or a serum-based proteomic approach [22].
We determined IFNc expression in T cells specific for latency-
associated antigens. TNFa-expression revealed comparable results
and a strongly overlapping cytokine expression pattern (data not
shown) while IL-2 expression was not detectable after 7 days of in
vitro restimulation (data not shown). Therefore T cells induced by
latency-associated antigens show a phenotype of multifunctional T
cells, which have been shown to protect against TB in the mouse
model [23]. We have shown recently that GM-CSF expressing
multifunctional T cells are not increased in TB patients while
other cytokines were increased in TB patients as compared to
LTBI [24]. Ongoing longitudinal prospective studies analyze
whether the frequency and phenotype of latency antigen-specific T
cells in LTBI is associated with the risk of developing TB at a later
time point and hence can be exploited for prognostic diagnosis
(www.biomarkers-for-tb.net). One important aspect that will be
addressed in these studies is the lack of T cells specific for latency-
associated antigens in active TB patients although it is likely that
most TB patients undergo a phase of latent infection prior to
active disease. As an initial attempt to address this point we
determined T-cell responses twice (prior to and under drug
treatment) for a subgroup of TB patients (data not shown) and
detected increased frequencies for some of the latency proteins in
patients under drug treatment. Therefore the lack of latency-
associated T cells at least for some antigens seems to be restricted
to the acute TB phase. This could be explained i) by the
recruitment of these T cells to the lung or ii) increased T-cell
regulation during the acute TB phase.
In contrast to intracellular IFNc analyses, some IFNc was also
detected in supernatants of PBMC from a subgroup of TST-
negative donors after stimulation with latency-associated antigens
as described previously [5]. The second round of restimulation did
not cause this higher background in TST-negative donors, since
supernatants collected at day 6 from a subgroup of uninfected
donors showed similar IFNc abundance as compared to the day 7
time point after restimulation (data not shown). Using flow
cytometry, we excluded the possibility that other immune cell
populations (e.g. NK cells, NKT cells, CD8
+ T cells) were the
source of IFNc (data not shown). A possible explanation would be
exhaustion or induced cell death (e.g. by apoptosis) after
restimulation 16 h prior to analysis [25]. Alternatively, these
donors could be false negative in the T-Spot TB although we
have no evidence to support this assumption, or these responses
reflect cross-reactivity towards antigens expressed by commensal
bacteria [26].
In an initial attempt to characterize the T-cell responses against
latency-associated antigens we compared the T-cell responses
against immunodominant and latency-associated antigens from
individual donors. While immunodominant antigens
ESAT6_CFP-10, TB10.4, Ag85a induced significantly stronger
T-cell responses in the 16-h short-term assay as compared to
latency-associated antigens (i.e. Rv0569, Rv1734, Rv2003),
comparable proportions of IFNc-producing T cells were detected
in the 7-day two rounds of restimulation assay. We conclude that a
simply ‘boosted’ T-cell response by prolonged stimulation and two
rounds of restimulation did not cause this effect as this would lead
to higher proportions of T cells specific for immunodominant
antigens. Distinct maturation stage of T-cell populations specific
for latency-associated antigens may account for these findings.
This may lead to differences in the activation threshold
prerequisite for in vitro cytokine expression. Previous studies
demonstrated higher sensitivity of a 6-day whole blood assay for
Table 3. Design of Rv3407 peptide pools.
No.
1 Amino acid sequence
P1 MRATVGLVEAIGIRE
P2 TVGLVEAIGIRELRQ
P3 LVEAIGIRELRQHAS
P4 AIGIRELRQHASRYL
P5 IRELRQHASRYLARV
P6 LRQHASRYLARVEAG
P7 HASRYLARVEAGEEL
P8 RYLARVEAGEELGVT
P9 ARVEAGEELGVTNKG
P10 EAGEELGVTNKGRLV
P11 EELGVTNKGRLVARL
P12 GVTNKGRLVARLIPV
P13 NKGRLVARLIPVQAA
P14 RLVARLIPVQAAERS
P15 ARLIPVQAAERSREA
P16 IPVQAAERSREALIE
P17 QAAERSREALIESGV
P18 ERSREALIESGVLIP
P19 REALIESGVLIPARR
P20 LIESGVLIPARRPQN
P21 SGVLIPARRPQNLLD
P22 LIPARRPQNLLDVTA
P23 ARRPQNLLDVTAEPA
P24 PQNLLDVTAEPARGR
P25 LLDVTAEPARGRKRT
P26 VTAEPARGRKRTLSD
P27 EPARGRKRTLSDVLN
P28 RGRKRTLSDVLNEMR
P29 KRTLSDVLNEMRDEQ
1Peptide number according to the position within the primary sequence from
C- to N-terminus.
doi:10.1371/journal.pone.0005590.t003
T Cells against Latent Mtb
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restimulation preferentially induced central memory T cells
[14,16]. This supports the notion that T cells specific for
latency-associated antigen have a distinct maturation/activation
status. Detailed investigation of both T-cell populations will be
performed in the future, including global gene expression profiling.
Materials and Methods
Ethics Statement
The clinical investigations have been conducted according to
the principles expressed in the Declaration of Helsinki. All donors
gave written informed consent and the local ethics committee of
the University Hospital Berlin at Charite ´ approved this study (205-
18.1; 205-18.2; 205-18.3).
Human subjects
Peripheral blood (40 ml) was obtained from 22 LTBI and 20
patients with active pulmonary TB. LTBI and TB patients were
recruited at HELIOS clinic Emil-von-Behring and the Charite ´,
both in Berlin; and at the Asklepios Clinic, Munich-Gauting.
Diagnosis of LTBI was based on positive TST (.10 mm) and
positive T-Spot TB
TM. TB diagnosis was based on patient history,
chest X-ray, TST, and mycobacterial culture. Ten M. tuberculosis
non-infected (TST-negative) donors were recruited among volun-
teers of the Max Planck Institute for Infection Biology, Berlin. All
Figure 4. Overlapping peptide pools of latency-associated protein Rv3407 stimulate IFNc-expressing CD4
+ T cells after 7 days and
two rounds of restimulation. PBMC from six LTBI (A–F) were restimulated with 15-mer synthetic peptide pools of Rv3407 for 7 days including two
rounds of in vitro restimulation. IFNc-expressing CD4
+ CD45RO
+ T cells are shown for stimulation with peptide pools 1 to 6 (grey bars) and pools 7 to
11 (black bars). Each peptide is constituent of one pool within pools 1 to 6 and of one pool within pools 7 to 11. Peptides inducing the most
prominent responses are indicated for donors A–D. The horizontal line indicates the threshold for positive responses (0.2%). Background values of
non-stimulated controls were subtracted.
doi:10.1371/journal.pone.0005590.g004
T Cells against Latent Mtb
PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5590donors were Caucasians. There was no gender bias and only
minor age differences between both study groups (Table 4).
Recombinant M. tuberculosis proteins and synthetic
peptide pools
Recombinant M. tuberculosis proteins (Table 1) were expressed in
Escherichia coli and purified as described previously [5,27].
Synthetic 15-mer peptide pools representing Rv3407 were
generated with an overlap of 12 amino acids using combinatory
chemistry (Jerini). The pools were designed as matrix pools as
described before [28]. The peptides are listed in Table 3.
Cell culture assays
Peripheral blood mononuclear cells (PBMC) were isolated by
density centrifugation (Biocoll, Biochrom) following manufactur-
Table 4. Characteristics of LTBI, TB patients and non-infected
donors.
LTBI
1 TB patients
2
Non-infected
donors
3
Total number 22 20 10
Female 11 10 5
Male 11 10 5
Age range years (median) 28–64 (47) 26–63 (41) 24–55 (36)
1healthy latently M. tuberculosis-infected donors.
2patients with active pulmonary TB.
3healthy tuberculin skin test (TST)-negative donors.
doi:10.1371/journal.pone.0005590.t004
Figure 5. Gating procedures of flow cytometry analyses to determine protein candidate specific T cell proportions. Representative
analyses from a patient with Tb (A) and an LTBI (B) are shown. Open red circles and dot plot connected by red arrows indicate the sequence of
analysis steps. First, lymphocytes were gated using size (forward scatter; FSC) and granularity (side scatter, SSC). These cells were then analyzed for
CD4 expression. CD4
+ T cells were analyzed for IFNc CD45RO expression for each stimulation (without stimulus, w/o; proteine 3; protein 11; SEB).
Proportions of CD45ROhigh IFNc expressing CD4
+ T cells (upper right quadrants) were determined. The background of non-stimulated T cells (w/o)
was subtracted for analyses.
doi:10.1371/journal.pone.0005590.g005
T Cells against Latent Mtb
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5 cells were cultured in 200 mL medium
A [(RPMI-1640 (GIBCO, Invitrogen) with 10% human serum
(Sigma-Aldrich), 100 U/ml penicillin, 100 mg/ml streptomycin,
1 mM L-glutamine and 10 mM HEPES (all PAA laboratories)]
using 96-well round-bottom plates (NUNC). Each well was
surrounded by wells filled with sterile water (200 ml) to avoid
drying effects. In the short-term assay we stimulated PBMC for
16 h with different recombinant M. tuberculosis proteins (5 mg/ml,
see Table 1), purified protein derivative (PPD) of M. tuberculosis
(5 mg/ml) (Statens Serum Institute), Staphylococcus enterotoxin B
(SEB) (1 mg/ml) (Sigma-Aldrich), and synthetic peptide pools
(5 mg/ml per peptide) at 37uC and 5% CO2. After 4 h of
incubation brefeldin A (10 mg/ml) (Sigma-Aldrich) was added.
In the long-term assay the same stimuli were applied at the
beginning except for SEB that was added on day 6 to a well of
non-stimulated cultured cells. For each of the other stimuli the
same antigen was added on day 6 in 20 ml medium A using the
same final concentrations. In the long-term assay, brefeldin A
(10 mg/ml) was added 4 h after the second restimulation only, and
cells were then cultured for an additional 12 h.
Afterwards, for both assays, cells were fixed and permeabilized
using cytofix/cytoperm
TM (BD Biosciences) following manufactur-
er’s instructions and stained with the following fluorochrome-
labeled monoclonal antibodies: a-CD3 (Pacific Blue) (BioLegend),
a-CD4 (APC-Cy7), a-CD8 (PerCP), a-CD45RO (Pe-Cy7), a-IFNc
(APC) (all BD Biosciences). After staining for 45 min at 4uC, cells
were washed twice in cytoperm/wash, and once in PBS containing
10% FCS. Measurements and analyses were performed using a
LSRII flow cytometer and FACS-Diva software (both BD
Biosciences). Examples of the procedures of analysis are shown in
Figure 5A for a TB patient and Figure 5B for an LTBI. About
18000 CD4
+ CD45RO
+ T cells were collected for each sample. For
background determinations, values of non-stimulated controls were
subtracted from the different stimuli of each individual donor.
Cytokine analyses in culture supernatants by ELISA
PBMC (5610
4) were added to 96-well round-bottom plates
(NUNC) in 200 mL medium. Cells were stimulated for 7 days as
described in the previous section but without adding brefeldin A.
We harvested 110 ml of cell culture supernatant at day 7. The
IFNc ELISA (BD Biosciences) was performed according to
manufacturer’s guidelines. Plates were analyzed by measuring
extinction at 450 nm using an ELISA plate reader (Molecular
Devices).
Donor classification and significance analyses
The discriminatory power for classifying TB patients and LTBI
was investigated using random forest analysis [29] based on the
proportion of IFNc-expressing CD4
+, CD45RO
+ T cells against
13 selected stimuli (i.e. PPD, ESAT6_CFP10, Rv0569, Rv1733c,
Rv1734, Rv2003, Rv2005c, Rv2006, Rv0140, Rv1009, Rv1884c,
Rv2450c, and Rv3407). We determined the relative feature
importance for discrimination using a leave-1-out cross validation
for all possible combinations of genes and assessed the proportion
of correctly classified patients in the left-out group.
For significance analyses the Mann-Whitney U-test was used.
Significance of two-sided p-values is indicated as follows: *
P,0.05, ** P,0.01, and *** P,0.001.
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